You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
匯鴻集團(600981.SH):子公司匯鴻醫藥轉讓醫寧公司股權事項實施完成
格隆匯 11-09 17:43

格隆匯 11 月 9日丨匯鴻集團(600981.SH)公佈,公司第九屆董事會第二次會議審議通過了《關於子公司江蘇匯鴻國際集團醫藥保健品進出口有限公司轉讓子公司股權的議案》。董事會同意公司全資子公司江蘇匯鴻國際集團醫藥保健品進出口有限公司(“匯鴻醫藥”)公開掛牌轉讓所持江蘇匯鴻醫寧健康管理有限公司(“醫寧公司”)51%股權,掛牌價格不低於2893.49萬元。2020年3月3日,轉讓方匯鴻醫藥與受讓方陳苡然簽署了《國有產權轉讓合同》,匯鴻醫藥將其持有的醫寧公司51%的國有股權通過江蘇省產權交易所公開交易程序轉讓給陳苡然。2020年3月18日,匯鴻醫藥收到江蘇省產權交易所出具的產權交易憑證(蘇產交【2020】32號),股權轉讓首期交易價款已支付,剩餘交易價款擔保手續已完成。2020年4月,醫寧公司工商變更登記手續已完成。

根據合同約定,受讓方陳苡然將在股權轉讓合同生效起12個月內支付剩餘交易價款。截至公告日,匯鴻醫藥已累計收到股權轉讓剩餘交易價款1446.745萬元及利息26.8801萬元。受讓方已按照合同約定的時間節點完成全部股權價款支付。此次股權轉讓交易事項已完成。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account